Spring 2022 Conference
Same-Day Registration is Still Open
After 2 years of virtual learning, our upcoming Spring 2022 conference is back to in-person. We are looking forward to seeing you again for learning and networking.
Multiple topics covering Diabetes are lined up. Click below to view our full agenda and line up of faculty.
Location: Seattle Convention Center
Address: 705 Pike Street, Seattle, WA 98101-2310
Date: Friday 6 May 2022
Time: 7:30 AM – 4:50 PM PDT
Virtual Option: We will be recording the live presentations and after the conference is complete, we will send registrants details on how to access the Enduring Materials and for how long.
For CME:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Washington State Medical Association and the Endocrine Days Educational Institute. The WSMA is accredited by the ACCME to provide continuing medical education for physicians.
The WSMA designates this Other activity (blended live course and enduring material) for a maximum of 6 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the criteria for up to 6 hour(s) of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
For MOC:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Planners: The following planners have indicated (a) relevant financial relationship(s) with an ACCME-defined ineligible company:
Savitha Subramanian, Abbott Diabetes Care, advisory board member; Amarin, advisory board member. Kristina Utzschneider, Nevro, consultant; Clinical Care Options, speaker.
All relevant financial relationships have been mitigated. All others in control of content have indicated no relevant financial relationship with an ACCME-defined ineligible company. All clinical content presented will be evidence-based and unbiased.
Faculty: The following faculty have indicated (a) relevant financial relationship(s) with an ACCME-defined ineligible company:
Katherine Tuttle, Eli Lilly & Company, consultant, speaker; Boehringer Ingelheim, consultant; AstraZeneca, consultant, speaker; Gilead, consultant, speaker; Goldfinch Bio, consultant, speaker, researcher; Novo Nordisk, consultant, speaker; Bayer, speaker, researcher; Travere, consultant, researcher.
All relevant financial relationships have been mitigated. All others in control of content have indicated no relevant financial relationship with an ACCME-defined ineligible company. All clinical content presented will be evidence-based and unbiased.